Candesartan cilexetil 32 MG TB 90S
Ended Awarded
- Contract number
- SPE2DR26F1021
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,117
Award facts
- Contract value 100% obligated
- $36,117.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,117.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles) on November 5, 2025, with completion due by November 6, 2025. This competitively awarded contract with no set-aside designation leverages AmerisourceBergen's established relationship with DLA as a critical pharmaceutical distributor supporting federal medical procurement. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, functions as a major pharmaceutical and healthcare solutions provider with extensive experience fulfilling federal medical supply requirements through the DLA's Medical Supply Chain. The company's contract portfolio demonstrates its capability to supply a diverse range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. As a prime vendor under the DLA Troop Support Medical framework, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, supporting military medical programs globally through flexible and competitively awarded delivery mechanisms.
Quick answers
Who was awarded contract SPE2DR26F1021?
SPE2DR26F1021 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26F1021 worth?
The government has obligated $36,117 on SPE2DR26F1021.
Is contract SPE2DR26F1021 an order under another contract?
Yes. SPE2DR26F1021 is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26F1021 competed?
The extent of competition for SPE2DR26F1021 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award